81 related articles for article (PubMed ID: 2640050)
1. Decline of circulating immune complexes in rheumatoid arthritis: patients treated with tiopronine.
Bendaoud B; Delecoeuillerie G; Katsikis P; Le Goff P; Youinou P
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):291-5. PubMed ID: 2640050
[TBL] [Abstract][Full Text] [Related]
2. [Tiopronin, an example of hydrosulphonated derivatives used in the treatment of rheumatoid polyarthritis. Study of immunologic effects].
Youinou P; Delecoeuillerie G; Fauquert P; Lelong A; Dumay A; Le Goff P
Rev Rhum Mal Osteoartic; 1990 Apr; 57(3 ( Pt 2)):287-91. PubMed ID: 1971455
[TBL] [Abstract][Full Text] [Related]
3. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Forster PJ; McConkey B
Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
[TBL] [Abstract][Full Text] [Related]
4. [The effect of treatment on circulating immune complexes in rheumatoid arthritis (author's transl)].
Rosenthal M; Graf U; Müller W
Dtsch Med Wochenschr; 1977 Mar; 102(12):415-8. PubMed ID: 844411
[TBL] [Abstract][Full Text] [Related]
5. IgA related disorders in rheumatoid arthritis.
Pillemer SR; Reynolds WJ; Yoon SJ; Perera M; Newkirk M; Klein M
J Rheumatol; 1987 Oct; 14(5):880-6. PubMed ID: 2963127
[TBL] [Abstract][Full Text] [Related]
6. [Tiopronine: new basic treatment for rheumatoid arthritis. Open study of 158 cases].
Pasero G; Pellegrini P; Ciompi ML; Colamussi V; Barbieri P; Mazzoni MR
Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):163-8. PubMed ID: 7384725
[TBL] [Abstract][Full Text] [Related]
7. [Tiopronine, new anti-rheumatic drug, has slow action in rheumatoid arthritis].
Amor B; Mery C; de Gery A
Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):157-62. PubMed ID: 7384724
[TBL] [Abstract][Full Text] [Related]
8. Effect of antimalarial treatment on circulating immune complexes in rheumatoid arthritis.
Segal-Eiras A; Segura GM; Babini JC; Arturi AS; Fraguela JM; Marcos JC
J Rheumatol; 1985 Feb; 12(1):87-9. PubMed ID: 3981522
[TBL] [Abstract][Full Text] [Related]
9. [Decrease of the functional affinity of rheumatoid factors under the effect of tiopronin].
Albouy R; Bendaoud B; Casburn-Budd R; Chicault P; Le Goff P; Paolozzi L; Péron A; Thorel JB; Tirel H; Youinou P
Rev Rhum Mal Osteoartic; 1991 Apr; 58(3 ( Pt 2)):43S-49S. PubMed ID: 2057710
[TBL] [Abstract][Full Text] [Related]
10. [Tiopronine and rheumatoid polyarthritis].
Amor B; Mery C; de Gery A; Zizi M
Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):39-43. PubMed ID: 3704511
[TBL] [Abstract][Full Text] [Related]
11. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
13. Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.
Jones VE; Jacoby RK; Wallington T; Holt P
Clin Exp Immunol; 1981 Jun; 44(3):512-21. PubMed ID: 6976861
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in rheumatoid arthritis. Selective removal by cryogelation with membrane filtration.
Krakauer RS; Asanuma Y; Zawicki I; Calabrese L; Malchesky P; Nose Y
Arch Intern Med; 1982 Feb; 142(2):395-7. PubMed ID: 6977346
[TBL] [Abstract][Full Text] [Related]
15. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis].
Steffen C; Smolen J; Miehlke K; Hörger I; Menzel J
Z Rheumatol; 1985; 44(2):51-6. PubMed ID: 4050140
[TBL] [Abstract][Full Text] [Related]
16. [Tolerability and therapeutic maintenance of tiopronin, new basic treatment of rheumatoid arthritis. Apropos of long-term follow-up of 268 cases].
Delecoeuillerie G
Rev Rhum Mal Osteoartic; 1989 Apr; 56(5 Pt 2):38-42. PubMed ID: 2740804
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of immune complexes in rheumatoid disease.
Fleming A; Charlesworth J; Liew M; Portek I; Bertouch J; Quin J
Aust N Z J Med; 1981 Jun; 11(3):231-4. PubMed ID: 6945832
[TBL] [Abstract][Full Text] [Related]
18. [Complement system in patients with rheumatoid arthritis related to administered drug therapy].
Kozlov DV; Kudriashova LP; Ivanova IV
Klin Med (Mosk); 1994; 72(5):43-7. PubMed ID: 7853815
[No Abstract] [Full Text] [Related]
19. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
